Release Date: 30/01/09 15:15 Summary: Quarterly Activities Report and Cash Flow Report Price Sensitive: Yes Download Document 1.15MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%